UNSPSC 85511109: Supplement left external iliac artery with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left external iliac artery with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04UJ07Z

UNSPSC 85511109 Supplement left external iliac artery with autologous tissue substitute, open approach is a Commodity code that does not align with recent state and local procurement activity. The code describes a specific vascular surgical procedure using medical device and tissue-substitute terminology drawn from clinical healthcare taxonomy (ICD-10-PCS), yet the six recent state and local opportunities posted under this code solicit services including independent medical evaluation and disability benefit administration, surgical carve-out benefit program administration, occupational medical surveillance, emergency and specialty medical care for detained youth, pharmacy benefit management, and temporary health professional staffing—none of which involve vascular surgery, device implantation, or the tissue-substitute protocols the code nominally describes. The issuing bodies span city pension boards, municipal human-resources departments, state transportation agencies, county juvenile detention authorities, county health-system procurement offices, and regional health networks across Arizona, California, Florida, Texas, and Washington.

The mismatch between the code's clinical-procedure scope and the service-contracting activity it indexes suggests a data-classification error in state and local procurement systems rather than a legitimate buying pattern. Vendors pursuing opportunities under this code should verify the actual scope of work in each RFP or RFQ notice rather than relying on the UNSPSC taxonomy alone, as the code does not accurately reflect what state and local governments are actually soliciting. No representative vascular-surgery-device or tissue-substitute procurement appears in the recent opportunity set.